FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317951857> ?p ?o ?g. }

• W4317951857 endingPage "281" @default.
• W4317951857 startingPage "281" @default.
• W4317951857 abstract "Importance Two recent meta-analyses reported a high prevalence of both anxiety and depression in patients with alopecia areata (AA), as well as a positive association of AA with anxiety and depression, without distinguishing between disorders and symptoms. Yet, depression and anxiety can manifest either as symptoms identified in questionnaires or as specific diagnoses defined by Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision criteria. Objective To perform a large meta-analysis separating the prevalence of depressive and anxiety disorders from that of depressive and anxiety symptoms in patients with AA. Data Sources PubMed, ScienceDirect, the Cochrane Library, Embase, and PsycINFO databases were searched from inception through August 1, 2020. Study Selection Studies that contained data on the prevalence of depressive or anxiety disorders or symptoms were included. Data Extraction and Synthesis The Meta-analysis of Observational Studies in Epidemiology ( MOOSE ) reporting guidelines were used. Pooled prevalence was calculated with a random effects model meta-analysis that took into account between- and within-study variability. Meta-regressions were used to study the association between variations in prevalence and study characteristics. Main Outcomes and Measures The prevalence of depressive and anxiety disorders and symptoms in patients with AA. Results Thirty-seven articles (29 on depression and 26 on anxiety) that met the inclusion criteria were identified. By distinguishing between disorders and symptoms, the prevalence of both depressive disorders (9%) and unspecified anxiety disorders (13%) in patients with AA was shown to be greater than that in the general population. The prevalence and odds ratio (OR) of depressive disorders (prevalence, 9%; OR, 1.38) and anxiety disorders of which each category had been specifically studied (prevalence, 7%-17%; OR, 1.51-1.69) were markedly lower than that of depressive symptoms (prevalence, 37%; OR, 2.70) and anxiety symptoms (prevalence, 34%; OR, 3.07). Meta-regressions showed that variations in prevalence were mainly associated with methodological differences between studies. Conclusions and Relevance In this systematic review and meta-analysis, the separate analyses showed that 7% to 17% of patients with AA had depressive or anxiety disorders that require psychiatric care, including specific medication. Additionally, more than one-third of patients had symptoms that are warning signs and that need monitoring because they can develop into disorders." @default.
• W4317951857 created "2023-01-25" @default.
• W4317951857 creator A5013394355 @default.
• W4317951857 creator A5047614421 @default.
• W4317951857 creator A5055216000 @default.
• W4317951857 creator A5059649505 @default.
• W4317951857 creator A5063194933 @default.
• W4317951857 creator A5068078504 @default.
• W4317951857 creator A5089382487 @default.
• W4317951857 date "2023-03-01" @default.
• W4317951857 modified "2023-10-16" @default.
• W4317951857 title "Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata" @default.
• W4317951857 cites W1999468608 @default.
• W4317951857 cites W2005241673 @default.
• W4317951857 cites W2034689582 @default.
• W4317951857 cites W2063277639 @default.
• W4317951857 cites W2064183265 @default.
• W4317951857 cites W2066991045 @default.
• W4317951857 cites W2071207313 @default.
• W4317951857 cites W2073694443 @default.
• W4317951857 cites W2078391925 @default.
• W4317951857 cites W2081460605 @default.
• W4317951857 cites W2119605658 @default.
• W4317951857 cites W2122087616 @default.
• W4317951857 cites W2125435699 @default.
• W4317951857 cites W2125481716 @default.
• W4317951857 cites W2140107414 @default.
• W4317951857 cites W2155959499 @default.
• W4317951857 cites W2157823046 @default.
• W4317951857 cites W2161701454 @default.
• W4317951857 cites W2192133534 @default.
• W4317951857 cites W2231488145 @default.
• W4317951857 cites W2245053702 @default.
• W4317951857 cites W2342083670 @default.
• W4317951857 cites W2346759038 @default.
• W4317951857 cites W2374483418 @default.
• W4317951857 cites W2519503335 @default.
• W4317951857 cites W2581163983 @default.
• W4317951857 cites W2596736776 @default.
• W4317951857 cites W2737734653 @default.
• W4317951857 cites W2758572380 @default.
• W4317951857 cites W2807669085 @default.
• W4317951857 cites W2883519784 @default.
• W4317951857 cites W2885934404 @default.
• W4317951857 cites W2897204831 @default.
• W4317951857 cites W2898459969 @default.
• W4317951857 cites W2910242025 @default.
• W4317951857 cites W2923748325 @default.
• W4317951857 cites W2946995879 @default.
• W4317951857 cites W2948468088 @default.
• W4317951857 cites W2955014968 @default.
• W4317951857 cites W2964127106 @default.
• W4317951857 cites W3013031997 @default.
• W4317951857 cites W3024730165 @default.
• W4317951857 cites W3091837328 @default.
• W4317951857 cites W4236086325 @default.
• W4317951857 cites W4239242064 @default.
• W4317951857 cites W4243993645 @default.
• W4317951857 cites W4247665917 @default.
• W4317951857 cites W4248516295 @default.
• W4317951857 cites W4255672777 @default.
• W4317951857 doi "https://doi.org/10.1001/jamadermatol.2022.6085" @default.
• W4317951857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36696123" @default.
• W4317951857 hasPublicationYear "2023" @default.
• W4317951857 type Work @default.
• W4317951857 citedByCount "7" @default.
• W4317951857 countsByYear W43179518572023 @default.
• W4317951857 crossrefType "journal-article" @default.
• W4317951857 hasAuthorship W4317951857A5013394355 @default.
• W4317951857 hasAuthorship W4317951857A5047614421 @default.
• W4317951857 hasAuthorship W4317951857A5055216000 @default.
• W4317951857 hasAuthorship W4317951857A5059649505 @default.
• W4317951857 hasAuthorship W4317951857A5063194933 @default.
• W4317951857 hasAuthorship W4317951857A5068078504 @default.
• W4317951857 hasAuthorship W4317951857A5089382487 @default.
• W4317951857 hasConcept C107130276 @default.
• W4317951857 hasConcept C118552586 @default.
• W4317951857 hasConcept C126322002 @default.
• W4317951857 hasConcept C139719470 @default.
• W4317951857 hasConcept C156957248 @default.
• W4317951857 hasConcept C16005928 @default.
• W4317951857 hasConcept C162324750 @default.
• W4317951857 hasConcept C2776317618 @default.
• W4317951857 hasConcept C2776478404 @default.
• W4317951857 hasConcept C2776867660 @default.
• W4317951857 hasConcept C2777524370 @default.
• W4317951857 hasConcept C2777527207 @default.
• W4317951857 hasConcept C558461103 @default.
• W4317951857 hasConcept C71924100 @default.
• W4317951857 hasConcept C95190672 @default.
• W4317951857 hasConceptScore W4317951857C107130276 @default.
• W4317951857 hasConceptScore W4317951857C118552586 @default.
• W4317951857 hasConceptScore W4317951857C126322002 @default.
• W4317951857 hasConceptScore W4317951857C139719470 @default.
• W4317951857 hasConceptScore W4317951857C156957248 @default.
• W4317951857 hasConceptScore W4317951857C16005928 @default.
• W4317951857 hasConceptScore W4317951857C162324750 @default.
• W4317951857 hasConceptScore W4317951857C2776317618 @default.

• next